Tag: Pfizer

Pfizer says Covid pill drastically reduces severe disease

by Issam AHMED with Claire DOYEN in Johannesburg WASHINGTON, United States (AFP) — Pfizer said Tuesday that clinical trials confirmed its Covid pill — a new type of treatment that should withstand the mutations seen with Omicron — drastically reduced hospitalizations and deaths among at-risk people by almost 90 percent. The announcement came as a real-world study from South Africa showed two doses of the Pfizer-BioNTech vaccine was 70 percent effective in stopping severe illness […]

Pfizer’s EUA application for 5 to 11 age group under review by PHL vaccine experts, says FDA

  (Eagle News) – Pfizer-BioNTech has already submitted its application for emergency use authorization (EUA) for the use of its vaccines to children aged 5 to 11 years old, and is now being evaluated by the Philippine vaccine experts’ panel, according to Food and Drug Administration chief Undersecretary Eric Domingo. Pfizer’s application has already been forwarded to the country’s vaccine experts for their evaluation as of late last week. Domingo said that Pfizer claims its […]

US authorizes Pfizer Covid booster for people aged 16 and 17

WASHINGTON, United States (AFP) — The US Food and Drug Administration (FDA) on Thursday expanded authorization of the Pfizer-BioNTech Covid booster to include 16- and 17-year-olds, amid growing concern over the Omicron variant’s ability to overcome immunity conferred by two shots. The FDA’s decision comes a day after the companies released the results of lab tests that showed three doses appeared effective against Omicron, while two doses were probably not enough to stop infection — […]

Pfizer/BioNTech says three doses ‘effective’ against Omicron

    by Sebastien ASH FRANKFURT, Germany (AFP) — Two doses of the BioNTech and Pfizer coronavirus vaccine may not be enough to protect against the Omicron strain, the companies warned Wednesday, but they stressed it was “still effective” after a third jab. The companies’ news was called reassuring by experts, and came as the first independent data from labs around the world emerged, suggesting that the new variant is better at evading vaccine-trained immunity […]

Pfizer seeks US approval for Covid boosters for ages 16-17

WASHINGTON, United States (AFP) — Pfizer announced Tuesday it was seeking US authorization for Covid booster shots among adolescents aged 16 and 17, as concerns grow about the impact of the new Omicron variant. The Food and Drug Administration (FDA) has so far only granted emergency use authorizations (EUAs) for boosters to people aged 18 and over, six months after their primary series of the Pfizer or Moderna Covid vaccine, or two months after the […]

Pfizer already working on Covid vaccine targeting Omicron: CEO

  NEW YORK, United States (AFP) — Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the new Omicron variant in case the current inoculation is not effective against the latest strain, the US drugmaker’s CEO Albert Bourla said Monday. Bourla told CNBC that his company on Friday began testing the current vaccine against the Omicron variant, which was first reported in South Africa and has reignited fears of a […]

PHL revises target doses of Nov. 29-Dec.1 “Bayanihan Bakunahan” to 9 million, sets 2nd jab drive on Dec. 15-17

  (Eagle News) – The Philippine government is targeting only nine million vaccine doses to be administered in the three-day National Covid-19 vaccination drive set from November 29 to December 1, the National Task Force Against Covid-19 said on Saturday. This was a revision of the original plan of administering 15 million Covid-19 vaccine doses. As this came about, the NTF also announced the holding of another three-day vaccination campaign from December 15 to 17. […]

Pfizer says Covid shot 100% effective in adolescents after 4 months

WASHINGTON, United States (AFP) — Pfizer and BioNTech said Monday their Covid-19 vaccine remained 100 percent effective in children 12 to 15 years old, four months after the second dose. The companies said that the new data, which involved 2,228 trial participants, will help support their applications for full approval in the United States and worldwide. No serious safety concerns were observed in individuals with at least six months of follow-up after the second dose. […]

US to buy 10 million Pfizer Covid-19 treatments for $5.3 billion

WASHINGTON, United States (AFP) — President Joe Biden on Thursday announced the United States is buying 10 million courses of Pfizer’s Covid-19 treatment pill, in a $5.3 billion deal he touted as “critical” to fighting the pandemic. Pfizer applied this week for US emergency use authorization for its Paxlovid antiviral pill, shown to be highly effective in preventing hospitalization and death among high-risk patients. While the deal hinges on the treatment’s approval by the Food […]

Pfizer asks US to authorize Covid pill

WASHINGTON, United States (AFP) — US pharmaceutical company Pfizer on Tuesday asked regulators to authorize its Covid pill after it was shown to cut hospitalization or death by nearly 90 percent among newly-infected high risk patients. The move comes a few weeks after Merck also approached the Food and Drug Administration seeking a green light for its antiviral capsule against the coronavirus. Experts see the oral medications as an invaluable addition to vaccines in the […]

Pfizer, BioNTech, Moderna making $1,000 profit every second: analysis

WASHINGTON, United States (AFP) — Pfizer, BioNTech and Moderna are making combined profits of $65,000 every minute from their highly successful Covid-19 vaccines while the world’s poorest countries remain largely unvaccinated, according to a new analysis. The companies have sold the vast majority of their doses to rich countries, leaving low-income nations in the lurch, said the People’s Vaccine Alliance (PVA), a coalition campaigning for wider access to Covid vaccines, which based its calculations on […]

Pfizer requests US emergency authorization for Covid booster for adults

WASHINGTON, United States (AFP) — Drugmakers Pfizer and BioNTech announced Tuesday they have formally submitted a request asking US officials for emergency authorization of their Covid-19 booster vaccine for people aged 18 and older. The move follows research published by the companies in late October indicating a third shot is 95.6 percent effective against symptomatic infection, based on clinical trials carried out on 10,000 people. The companies asked the US Food and Drug Administration to […]